The report – which can be viewed here – highlights the following new medicines: 1) Novo Nordisk's Awiqli (LAI 287; insulin ... fixed-dose combination of an amylin analogue and GLP-1 agonist ...
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
Patients with type 1 diabetes comorbid with metabolic dysfunction-associated steatotic liver disease had a low prevalence of advanced liver fibrosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback